Medical Technology News | MedTech Dive
WEBUFP to buy device component maker AQF Medical, extending deal spree. AQF makes foam and thermoplastic components for use in medical devices and packaging. MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, …
Medical Device News - MedTech Dive
WEB3 days ago · Merit Medical inks $210M takeover of Cook’s lead management business. Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales. By Nick Paul Taylor • …
FDA touts lessons from Pre-Cert, though next steps murky
WEBSep 15, 2020 · FDA on Monday provided a 2020 update on its yet-to-be finalized software precertification program as well as ” learnings” from an ongoing pilot launched in 2019, which includes Apple, Fitbit, Johnson & Johnson and six other companies. The so-called Pre-Cert program is meant to fast-track digital health products to market by reducing ...
Roche to take on Abbott, Dexcom with its first CGM
WEBMar 7, 2024 · Dive Brief: Roche shared details of its plans to enter the continuous glucose monitor (CGM) market, unveiling the Accu-Chek Smartguide at the Advanced Technologies and Treatments for Diabetes conference in Florence, Italy. On Thursday, the company released data on a 14-day sensor that could compete with Abbott and Dexcom for the …
Abbott and Dexcom are launching the first over-the-counter …
WEBJun 26, 2024 · The new devices could allow the companies to reach about 25 million people in the U.S. with Type 2 diabetes who don’t take insulin, 15 million people who have been diagnosed with pre-diabetes and an estimated 85 million people who have undiagnosed pre-diabetes, William Blair analyst Margaret Kaczor Andrew said in an interview.
Medtronic will spin out slower-growth patient monitoring, …
WEBOct 24, 2022 · Dive Insight: Medtronic is the latest medtech company to consider a spinoff strategy, following Johnson & Johnson, GE, Becton Dickinson and others that are looking to focus on their core businesses. While analysts had initially pegged Medtronic’s diabetes business as a likely spinoff candidate, the company instead created a new operation …
J&J to buy heart device maker Abiomed for $16.6B in year’s largest ...
WEBNov 1, 2022 · Johnson & Johnson agreed t o acquire Abiomed, a Danvers, Mass.-based maker of heart pumps, for $16.6 billion. The deal will contribute to J&J’s cardiovascular portfolio, complementing its Biosense Webster electrophysiology business, BTIG Analyst Marie Thibault wrote in a research note on Tuesday. The deal has already been …
What does a more aggressive M&A approach mean for J&J's …
WEBFeb 22, 2022 · In his first earnings call as CEO of Johnson & Johnson, Joaquin Duato set a course for an “aggressive” M&A strategy, especially when it comes to medical devices. Duato, who became CEO on Jan. 3, is looking for products in higher-growth markets where J&J can take a leading position. Duato said during a January earnings call that the …
MedTech Mergers & Acquisitions | MedTech Dive
WEB4 days ago · Merit Medical inks $210M takeover of Cook’s lead management business. Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales. By Nick Paul Taylor • …
How AI and machine learning are changing prosthetics
WEBMar 29, 2019 · Driving demand are aging populations and rising incidence of vascular diseases, as well as developments in artificial intelligence and machine learning. Advanced materials such as silicone and urethanes are also resulting in lighter-weight prosthetics with “memory” to respond to changes in pressure. Among those competing in the space are ...
Skip to content